Immunome (IMNM) Equity Ratio: 2023-2025
Historic Equity Ratio for Immunome (IMNM) over the last 3 years, with Sep 2025 value amounting to 0.88.
- Immunome's Equity Ratio rose 5.38% to 0.88 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.88, marking a year-over-year increase of 5.38%. This contributed to the annual value of 0.75 for FY2024, which is 6.56% down from last year.
- According to the latest figures from Q3 2025, Immunome's Equity Ratio is 0.88, which was down 3.00% from 0.91 recorded in Q2 2025.
- In the past 5 years, Immunome's Equity Ratio registered a high of 0.91 during Q2 2025, and its lowest value of 0.07 during Q3 2023.
- Over the past 3 years, Immunome's median Equity Ratio value was 0.84 (recorded in 2024), while the average stood at 0.67.
- Data for Immunome's Equity Ratio shows a peak YoY increase of 1,182.64% (in 2024) and a maximum YoY decrease of 6.56% (in 2024) over the last 5 years.
- Immunome's Equity Ratio (Quarterly) stood at 0.81 in 2023, then fell by 6.56% to 0.75 in 2024, then rose by 5.38% to 0.88 in 2025.
- Its last three reported values are 0.88 in Q3 2025, 0.91 for Q2 2025, and 0.90 during Q1 2025.